ALKERMES | ALKS - 股票

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	股票	更改		日
AbbVie	USD 4.95B		13M	2025-12
Acadia Pharmaceuticals	USD 34.67M		5.57M	2025-12
ALKERMES	USD 196.62M		5.63M	2025-12
Amgen	USD 6.22B		121M	2025-12
Biogen	USD 2.17B		41.3M	2025-12
BioMarin Pharmaceutical	USD 1.3B		83.29M	2025-12
Bristol-Myers Squibb	USD 2.76B		21M	2025-09
Coherus Biosciences	USD 3.17M		1.12M	2025-12
Eli Lilly	USD 13.74B		1.56B	2025-12
Gilead Sciences	USD 1.77B		11M	2025-12
Heron Therapeutics	USD 54.57M		2.33M	2022-12
Ionis Pharmaceuticals	USD 10.47M		1.99M	2025-09
J&J	USD 14.58B		392M	2026-03
Merck	USD 6.44B		157M	2025-09
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Neurocrine Biosciences	USD 69M		300K	2025-12
Otsuka Holdings	JPY 350.53B		42.43B	2025-06
Pfizer	USD 11.47B		201M	2025-09
Regeneron Pharmaceuticals	USD 3.2B		53.6M	2025-12
Vertex Pharmaceuticals	USD 1.69B		60M	2025-12